Trethera presenting at the 2018 San Diego Health Impact Forum
Trethera will be presenting at the 2018 San Diego Health Impact Forum on February 7th, 2018 held at the Sanford Consortium for Regenerative Medicine in La Jolla, CA.
Trethera attending the 59th ASH Annual Meeting in Atlanta
/in Events /by adminNovember 27, 2017 – Trethera Corporation will be attending the American Society of Hematology (ASH) Annual Meeting in Atlanta from December 9-12, 2017. Trethera is preparing for initiation of a Phase 1 clinical trial in myelodysplastic syndrome (MDS) for its small molecule, deoxycytidine kinase inhibitor, TRE-515.
Trethera at BioPharm America
/in Events /by adminSeptember 7, 2017 – Trethera, a biotechnology company developing innovative small molecule inhibitors of cancer nucleotide metabolism, will be attending the BioPharma America conference in Boston, MA, September 26-27, 2017.
Trethera to attend RESI Boston 2017
/in Events /by adminSeptember 7, 2017 – Trethera, a biotechnology company developing innovative small molecule inhibitors of cancer nucleotide metabolism, will be attending RESI Boston 2017 on September 26, 2017.
SOHO 2017 Annual Meeting
/in Events /by adminSeptember 7, 2017 – Trethera will be attending the Society of Hematologic Oncology’s Annual Meeting, September 13-15, 2017, in Houston, Texas.
For more information on Trethera’s attendance, please contact info@trethera.com
Biocom’s Global Life Science Partnering Conference, 2017
/in Events /by admin1-2 March 2017
La Jolla, CA
Biocom’s Global Life Science Partnering Conference, 2016
/in Events /by adminFebruary 24 – 25, 2016
BIO International Convention, 2016
/in Events /by admin6-9 June 2016
San Francisco, CA
ASCO Annual Meeting, 2016
/in Events /by admin3-7 June 2016
Chicago, IL